Success Stories: EB1-A Approval Received for an Assistant Research Professor in Biomedical Science with Our Team’s Efficient Case Preparation Strategy
Client’s Testimonial:
“This is great to know that my I-140 is approved. Indeed our joint effort for this is paid off.”
On November 27th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Research Professor in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Assistant Research Professor
Country of Origin: India
State of Residence at the Time of Filing: Virginia
Approval Notice Date: November 27th, 2021
Processing Time: 7 months, 26 days
Case Summary:
Our client from India is one of the few leading experts in cell and tissue biomechanics and mechanotransduction research in the field of biomedical science. He is especially well-known for his work on the dynamic remodeling of cytoskeletons and mechanotransduction in the regulation of epithelial tissue adhesions, which is imperative for tissue integrity for maintaining healthy and functional organs in humans. He came to us in July 2020 seeking help with his EB1-A (Alien of Extraordinary Ability) application. Knowing well that the USCIS demands clear evidence of the petitioner's extraordinary ability in the said area, our team set out to collect proof for the client. This resulted in a thorough background check routed through his CVs, transcripts, and certificates both professional and academic. We were able to find the following:
- The field has recognized the client’s authority by inviting him to review and evaluate the work of his peers no fewer than 15 times.
- He has actively engaged his peers in the field of biomedical science by authoring and co-authoring 19 peer-reviewed articles and 2 book chapters that have been published in international journals.
- Additionally, his overall work related to the improvement of knowledge on the role of the cytoskeleton and its associated proteins which improves therapeutic approaches for various diseases such as cancer has been cited 748 times by peers using his prior findings to advance their respective studies.
- We added two visual representations, a map, and a table, of countries whose institutions have cited his work and for further reference, we prepared visualizations of this information.
“[The client’s] research offers significant benefits to the biomedical science community in the United States and advances the ability of clinical practitioners to care for patients with a broad range of chronic diseases, such as fibrotic organ conditions like pulmonary fibrosis. In light of his success to date, [the client’s] continuing research is irrefutably vital to aiding American healthcare. The biomedical science community would certainly suffer an irreparable loss if [the client] is unable to continue his research studies in the United States.”
“By investigating alternative therapeutic agents and improving the knowledge of disease mechanisms, [the client] has made great strides in the medical community's ability to successfully fight one of the most common chronic diseases in the United States. His biomedical science work is thus imperative to safeguarding American health and wellbeing, and I strongly encourage the United States to retain [the client’s] expertise and talents.”
Thus, when the application came through with an approval we were excited to share the information with our client. Our firm wishes him the very best in all future endeavors and thanks him for his trust in us.